Vir Biotechnology, Inc.
HealthcareNASDAQ:VIR · NASDAQ Global Select
+$0.09 today
Vol 1.11M · Avg 1.88M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+64.94%
Period High
$11.09
Period Low
$4.28
Latest
$8.61
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Day One Biopharmaceuticals, Inc.
DAWN
$2.22B
Iovance Biotherapeutics, Inc.
NASDAQ:IOVA
$1.46B
Kura Oncology, Inc.
NASDAQ:KURA
$803.41M
Geron Corporation
NASDAQ:GERN
$737.75M
Replimune Group, Inc.
NASDAQ:REPL
$733.24M
Maravai LifeSciences Holdings, Inc.
NASDAQ:MRVI
$722.58M
Ginkgo Bioworks Holdings, Inc.
NYSE:DNA
$515.41M
Prime Medicine, Inc.
NASDAQ:PRME
$501.21M
YD Bio Limited Ordinary Shares
NASDAQ:YDES
$231.62M
LENZ Therapeutics, Inc.
NASDAQ:LENZ
$212.27M
What is the latest VIR filing?
The latest filing shown is 8-K dated Jun 10, 2026.
How many recent filings does VIR have?
Intrinsic Alpha currently shows 20 recent filings for VIR.
Explore More
Continue the stock analysis
Jump to another research area for this company.